What We’re Reading, October 21, 2016: KEYNOTE-045 for pembrolizumab stopped early; new recommendations for digital media use by children; and Walgreens merger with Rite Aid pushed to 2017.
The phase 3 KEYNOTE-045 trial for pembrolizumab (Keytruda) evaluating the drug in previously treated patients with bladder cancer has been stopped early after it met its primary endpoint of overall survival. The programmed death-1 inhibitor proved superior to the investigator choice of chemotherapy—either paclitaxel, docetaxel, or vinflunine—in patients with metastatic or locally advanced or inoperable urothelial cancer that had failed to respond to platinum-based chemotherapy. Merck, the company developing pembrolizumab, is evaluating the drug in over 360 clinical trials in 30 tumor types.
Digital addiction in children may not be as bad as most presume. The American Academy of Pediatrics has released a policy statement providing guidance on age-based screen time for children. The guidance, published in the journal Pediatrics, goes as far as to say that parents can be a part of this experience for their children and that video chatting might actually be healthy. Following are a few of the recommendations:
Walgreens and Rite Aid have pushed back the deadline to close their merger. The Wall Street Journal reports that the $9.4 billion merger is expected to come to fruition early next year following delays in selling stores—a requirement for regulatory approval. The companies will sell between 500 and 1000 stored combined. Experts have raised doubts over whether the deal will eventually transpire, which led to an affirmation on the deal by Walgreens. Share prices for both companies saw a subsequent jump: 7.9% for Rite Aid and 3.8% for Walgreens.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More